Scientists have discovered a biological marker that may help to identify which depressed patients will respond to an experimental, rapid-acting antidepressant like ketamine. The brain signal, detectable by noninvasive imaging, also holds clues to the agent's underlying mechanism, which are vital for drug development, say NIH researchers.
A new study reveals that most of the specific genes long thought to be linked to intelligence probably have no bearing on one’s IQ. And it may be some time before researchers can identify intelligence’s specific genetic roots.
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment.
Researchers mobilize the brain's native stem cells to replenish medium spiny neurons which are lost in Huntington's disease.
Researchers identify a molecular pathway which accelerates the time taken for antidepressants to work in mouse models.
A new study provides a glimpse into the current limitations and powerful implications of precision medicine.
Researchers isolated a protein which is increased during indurance exercise and gave it to non-exercising mice. The protein turned on genes which promote brain health and encouage new neurons to grow.
Studying juvenile zebra finches, researchers discover a mechanism which could possibly be responsible for the differences in the intensity of song learning.
Researchers find a gene variant which could cause some people to be more impaired by TBI than others.
Researchers have identified six new genetic variants associated with habitual coffee drinking.